-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
-
Summary
-
CNS Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from Q2 2020 to Q3 2025.
- CNS Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2025 was -107 %, a 79.2% increase year-over-year.
- CNS Pharmaceuticals, Inc. annual Return On Assets for 2024 was -294 %, a 30.3% increase from 2023.
- CNS Pharmaceuticals, Inc. annual Return On Assets for 2023 was -421 %, a 252% decline from 2022.
- CNS Pharmaceuticals, Inc. annual Return On Assets for 2022 was -120 %, a 1.57% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)